Document is current
Any future updates will be listed below
-
Authors
Yuan, Junli
Chen, Yuanyuan
Wang, Lu
Xu, Meiping
Liao, Na
Dai, Zhiyue
Chen, Hui
Zhang, Binjun
Xu, Jinling
Wan, Minghui
Xu, Suzhong
Wang, Yuwen
Huang, Xiaolin
Zheng, Fuhao
Huang, Pingping
Chen, Jie
Huang, Chang-Bing
Yan, Fang-Fang
Yu, Xinping
Yu, Huanyun https://orcid.org/0000-0003-4072-8234
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2300075594 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Effect of Individualized and Adaptive Vision Training versus 6 hours of Patching in Children with Residual Amblyopia: A Randomized Clinical Trial
https://doi.org/10.1007/s40123-025-01287-9
-
Funding
Funding for this research was provided by:
Key Technologies Research and Development Program (2023YFC3604100)
Science and Technology Innovation 2025 Major Project of Ningbo (2022ZD0204800)
National Natural Science Foundation of China (32071056, 32100864)
- License Information
-
More Information
Article History
Received: 1 September 2025
Accepted: 18 November 2025
First Online: 9 December 2025
Declarations
:
: Chang-Bing Huang have equity interest in Jiangsu Juehua Medical Technology Co., LTD. Junli Yuan, Yuanyuan Chen, Lu Wang, Meiping Xu, Na Liao, Zhiyue Dai, Hui Chen, Binjun Zhang, Jinling Xu, Minghui Wan, Suzhong Xu, Yuwen Wang, Xiaolin Huang, Fuhao Zheng, Pingping Huang, Jie Chen, Fang-Fang Yan, Xinping Yu, and Huanyun Yu have nothing to disclose.
: The study protocol and informed consent were approved by the Ethics Committee of the Affiliated Optometry Hospital of Wenzhou Medical University (2022-248-K-198). Written informed consent was obtained from the parents or guardians of each study participant. The retrospectively registered study (ChiCTR2300075594, registered on 8 September 2023) adhered to the principles of the Declaration of Helsinki and was monitored by an independent data and safety monitoring committee.
